BiotechTV - News

Oxford, UK based OMass Therapeutics, experts in the use of mass spectrometry in drug development, recently landed a $20M up front licensing deal with Roche on one of its preclinical candidates for IBF

Listen Later

CEO Ros Deegan discusses the deal and the path to getting there, and she highlights some of OMass' other programs the company is driving forward alone, including an MC2 antagonist. Plus, the company's unique expertise in the use of mass spec.

...more
View all episodesView all episodes
Download on the App Store
BiotechTV - NewsBy BiotechTV
  • 5
  • 5
  • 5
  • 5
  • 5

5

4 ratings

More shows like BiotechTV - News

View all
Planet Money by NPR

Planet Money

30,626 Listeners

Odd Lots by Bloomberg

Odd Lots

1,863 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,085 Listeners

The Readout Loud by STAT

The Readout Loud

325 Listeners

The Journal. by The Wall Street Journal & Spotify Studios

The Journal.

6,059 Listeners

Biotech 2050 Podcast by Biotech 2050

Biotech 2050 Podcast

60 Listeners

All-In with Chamath, Jason, Sacks Friedberg by All-In Podcast, LLC

All-In with Chamath, Jason, Sacks Friedberg

9,840 Listeners

Business Of Biotech by Ben Comer

Business Of Biotech

86 Listeners

BioCentury This Week by BioCentury

BioCentury This Week

34 Listeners

Biotech Hangout by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Biotech Hangout

19 Listeners

ACQ2 by Acquired by Ben Gilbert and David Rosenthal

ACQ2 by Acquired

260 Listeners

BG2Pod with Brad Gerstner and Bill Gurley by BG2Pod

BG2Pod with Brad Gerstner and Bill Gurley

497 Listeners

The Studio at Kendall Square by BiotechTV

The Studio at Kendall Square

0 Listeners

Off-Target Effects with Matt Gline by BiotechTV

Off-Target Effects with Matt Gline

4 Listeners

Biotech CEO Sisterhood by BiotechTV

Biotech CEO Sisterhood

2 Listeners

BioVenture VoiCes with Chris Garabedian by BiotechTV

BioVenture VoiCes with Chris Garabedian

6 Listeners